Scarica l'app Stockscreener
12.45
2.07%
-0.265
Panoramica
Notizia
Cronologia dei prezzi
Financials
Perché TNXP Giù?
Forum
Previsione
Frazionamento azionario
Tonix Pharmaceuticals Holding Corp Borsa (TNXP) Ultime notizie
TNXP Stock Dives For Four Straight Sessions — Retail Eyes Drug Pipeline Payoff - Stocktwits
Technical Reactions to TNXP Trends in Macro Strategies - Stock Traders Daily
Tonix: 'Hold' Based On Tonmya Payer Expansions And MDD Trial Initiation - Seeking Alpha
symbol__ Stock Quote Price and Forecast - CNN
Tonix Pharmaceuticals Holding Corp. has enrolled the first patient in its Phase 2 “HORIZON” study of TNX-102 SL (sublingual tablet) for the treatment of major depressive disorder (MDD). - Bitget
Tonix: Slow Start For Tonmya, Speculative Pipeline Warrants Hold Rating (NASDAQ:TNXP) - Seeking Alpha
Tonix enrolls first patient in Phase 2 depression study - grafa.com
Tonix Pharmaceuticals Announces First Patient Enrolled in Phase 2 HORIZON Study of TNX-102 SL for the Treatment of Major Depressive Disorder (MDD) - The Manila Times
Tonix Pharmaceuticals Announces First Patient Enrolled in Phase 2 HORIZON Study of TNX-102 SL for Major Depressive Disorder - Quiver Quantitative
Tonix Pharmaceuticals Announces First Patient Enrolled in - GlobeNewswire
Tonix starts Phase 2 depression trial for TNX-102 SL - Stock Titan
Why TNXP Stock Is Suddenly Back On Retail Radar - Stocktwits
TNXP Slips After Hours On Slower Than Expected Launch For Fibromyalgia Drug - Stocktwits
Tonix Pharmaceuticals Holding Corp. Actuals & Estimates (DUS:TPM0) - TradingView
Enterprise value to revenue forward of Tonix Pharmaceuticals Holding Corp. – NASDAQ:TNXP - TradingView
Tonix Pharmaceuticals Holding Corp. Actuals & Estimates (NASDAQ:TNXP) - TradingView
Tonix Pharmaceuticals Holding Corp. Actuals & Estimates (FWB:TPM0) - TradingView
Enterprise value to EBIT forward of Tonix Pharmaceuticals Holding Corp. – NASDAQ:TNXP - TradingView
Price to sales forward of Tonix Pharmaceuticals Holding Corp. – NASDAQ:TNXP - TradingView
Tonix Pharmaceuticals (TNXP) Receives Strong Buy Rating with $26 Target - GuruFocus
TNXP Forecast — Price Target — Prediction for 2027 - TradingView
TNXP Initiated Coverage by Raymond James -- Price Target Set at $26 - GuruFocus
This Tonix Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - Sahm
Raymond James initiates Tonix Pharma stock coverage with strong buy By Investing.com - Investing.com South Africa
Raymond James initiates Tonix Pharma stock coverage with strong buy - Investing.com
TNXP Stock Rises Premarket: Investors Cheer Early Traction For Fibromyalgia Drug Despite Weak Q4 Print - Stocktwits
Tonix Pharmaceuticals Holding Corp (TNXP) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Trading the Move, Not the Narrative: (TNXP) Edition - Stock Traders Daily
Millennium Management LLC Increases Stake in Tonix Pharmaceuticals Holding Corp - GuruFocus
Millennium Management LLC Increases Stake in Tonix Pharmaceutica - GuruFocus
Tonix Pharmaceuticals Holding (TNXP) price target decreased by 15.76% to 55.42 - MSN
Tonix Pharmaceuticals Holding Corp (TNXP) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Tonix Pharmaceuticals Holding Corp (TNXP) Institutional Confidence - TradingKey
Tonix Pharmaceuticals Holding Corp - TradingKey
Tonix Pharmaceuticals Holding Corp (TNXP) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Tonix Pharmaceuticals (TNXP) Investor presentation Summary - Quartr
Tonix Pharmaceuticals Holding Corp (TNXP) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Tonix Pharmaceuticals Holding Corp (TNXP) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Tonix Pharmaceuticals Holding Corp (TNXP) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Tonix Pharmaceuticals Holding Corp (TNXP) Valuation: PE, PB & Fair Value Analysis - TradingKey
Tonix Pharmaceuticals Holding Corp at RBC Capital Markets Global Healthcare Conference Transcript - GuruFocus
Millennium group reports 890,366 shares (5.6%) in Tonix (TNXP) - Stock Titan
Insider Buying: Carolyn Taylor Acquires Shares of Tonix Pharmace - GuruFocus
Tonix Pharmaceuticals director Taylor buys $14,928 in stock By Investing.com - Investing.com South Africa
Tonix Pharmaceuticals director Taylor buys $14,928 in stock - Investing.com
Director Carolyn Taylor buys Tonix Pharmaceuticals (TNXP) shares in open market - Stock Titan
We're Keeping An Eye On Tonix Pharmaceuticals Holding's (NASDAQ:TNXP) Cash Burn Rate - Yahoo Finance
Tonix Pharmaceuticals Holding Corp (TNXP) Stock Price, Quote, News & History - Benzinga
1.83%
3.59%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):